- Home
- ANVS vs FONR Comparison
ANVS vs FONR Comparison
Compare ANVS & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- FONR
- Stock Information
- Founded
- ANVS 2008
- FONR 1978
- Country
- ANVS United States
- FONR United States
- Employees
- ANVS N/A
- FONR N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ANVS Health Care
- FONR Health Care
- Exchange
- ANVS Nasdaq
- FONR Nasdaq
- Market Cap
- ANVS 92.6M
- FONR 95.7M
- IPO Year
- ANVS 2020
- FONR 1987
- Fundamental
- Price
- ANVS $5.01
- FONR $15.22
- Analyst Decision
- ANVS Strong Buy
- FONR
- Analyst Count
- ANVS 6
- FONR 0
- Target Price
- ANVS $29.67
- FONR N/A
- AVG Volume (30 Days)
- ANVS 488.6K
- FONR 9.4K
- Earning Date
- ANVS 11-08-2024
- FONR 02-12-2025
- Dividend Yield
- ANVS N/A
- FONR N/A
- EPS Growth
- ANVS N/A
- FONR N/A
- EPS
- ANVS N/A
- FONR 1.42
- Revenue
- ANVS N/A
- FONR $102,006,089.00
- Revenue This Year
- ANVS N/A
- FONR N/A
- Revenue Next Year
- ANVS N/A
- FONR N/A
- P/E Ratio
- ANVS N/A
- FONR $10.70
- Revenue Growth
- ANVS N/A
- FONR 0.70
- 52 Week Low
- ANVS $4.21
- FONR $14.05
- 52 Week High
- ANVS $20.00
- FONR $24.05
- Technical
- Relative Strength Index (RSI)
- ANVS 44.02
- FONR 47.95
- Support Level
- ANVS $4.61
- FONR $15.03
- Resistance Level
- ANVS $4.95
- FONR $15.40
- Average True Range (ATR)
- ANVS 0.38
- FONR 0.29
- MACD
- ANVS 0.07
- FONR 0.03
- Stochastic Oscillator
- ANVS 40.40
- FONR 70.41
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.